From October 1, 2021 to December 31, 2021, the company has repurchased 4,748,693 shares, representing 0.32% for CNY 97.94 million. With this, the company has completed the repurchase of 7,790,608 shares, representing 0.52% for CNY 149.99 million under the buyback announced on August 6, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.3 CNY | -1.14% | -0.23% | +17.93% |
05-13 | Huahai Pharmaceutical's Unit Gets Nod to Register Atomoxetine Hydrochloride Oral Solution | MT |
05-02 | Huahai Pharmaceutical's Q1 Profit Jumps 57%, Income Up 21% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.93% | 3.5B | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- 600521 Stock
- News Zhejiang Huahai Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Huahai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 6, 2021.